News Sentiment

THC sentiment intelligence

Tenet Healthcare Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 69 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Medical Care Facilities Read-through group
Latest close 204.25 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 69

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend inactive

+0.3% over one week, +16.9% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Does Tenet Healthcare's (THC) Soft Guidance Undercut Its Strong Cash Generation Story?

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 0.3% Price digesting
Trend fit Trend inactive 16.9% over four weeks
Fair value 42.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 30
Neutral 32
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 69
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
TradingView 8
simplywall.st 5
GuruFocus 4
Investing.com 4
StockStory 4
AlphaStreet 2
TMX Newsfile 2

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 19
Analyst action 10
Guidance 2
Capital return 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 69
FinancialContent Direct company coverage

Why Tenet Healthcare (THC) Stock Is Trading Up Today

Tenet Healthcare (THC) shares rose 4.4% in the afternoon session after Bank of America reaffirmed its Buy rating, despite lowering its price target due to concerns about a worsening "payer mix." The analyst highlighted Tenet's strong cash generation and liquidity, which position

Tone
Positive 64/100
Event
Analyst action
Published
15 Jul 2026 22:55
Source
FinancialContent
The Globe and Mail Direct company coverage

Analysts Offer Insights on Healthcare Companies: Erasca (ERAS) and Tenet Healthcare (THC)

Jefferies and H.C. Wainwright have issued "Buy" ratings for Erasca (ERAS), with price targets of $24.00 and $20.00 respectively, reflecting a "Strong Buy" consensus. Similarly, Truist Financial and Barclays have maintained "Buy" ratings for Tenet Healthcare (THC), with price targ

Tone
Positive 76/100
Event
Market update
Published
15 Jul 2026 20:45
Source
The Globe and Mail
TradingView Direct company coverage

Why Tenet Healthcare (THC) Shares Are Plunging Today

Tenet Healthcare (THC) shares plunged 7% following a sector-wide sell-off triggered by HCA Healthcare cutting its full-year 2026 profit forecast. HCA attributed the cut to a shift in "payer mix" towards more uninsured patients, raising investor concerns about the financial impact

Tone
Negative 29/100
Event
Earnings
Published
14 Jul 2026 20:13
Source
TradingView
AlphaStreet Direct company coverage

Tenet Healthcare Drops 6.2% After Wells Fargo Maintains Overweight

Tenet Healthcare Corporation experienced a 6.2% drop in its stock price despite Wells Fargo and Barclays maintaining "Overweight" ratings and increasing their price targets. The sell-off, despite positive analyst sentiment, suggests potential profit-taking or broader sector press

Tone
Negative 30/100
Event
Analyst action
Published
14 Jul 2026 15:13
Source
AlphaStreet
GuruFocus Direct company coverage

Tenet Healthcare Corp (THC) Stock Down 4.6% but Still Overvalued -- GF Score: 77/100

Tenet Healthcare Corp (THC) shares have dropped 4.6% to $194.81, but are still considered 18.2% overvalued according to GuruFocus's GF Value™, which estimates a fair value of $164.77. The company holds a GF Score™ of 77/100, indicating above-average performance, primarily driven

Tone
Negative 29/100
Event
Market update
Published
14 Jul 2026 01:12
Source
GuruFocus
GuruFocus Direct company coverage

THC Maintained by Wells Fargo -- Price Target Raised to $231

Wells Fargo has maintained an 'Overweight' rating for Tenet Healthcare (THC), increasing its price target from $213.00 to $231.00. While analysts have a positive outlook, GuruFocus indicates the stock is currently 24.0% overvalued with a GF Value™ of $164.77 versus its current pr

Tone
Positive 66/100
Event
Analyst action
Published
13 Jul 2026 13:10
Source
GuruFocus
Fortune Direct company coverage

Tenet Healthcare (THC) Q1 2026 Earnings Call Transcript

This article provides the transcript for Tenet Healthcare's (THC) Q1 2026 earnings call. The transcript is powered by Quartr and details the financial discussion from the company's first quarter.

Tone
Neutral 50/100
Event
Earnings
Published
11 Jul 2026 23:10
Source
Fortune
Market source Direct company coverage

Tenet Healthcare (THC) Stock Sinks As Market Gains: Here's Why

Tenet Healthcare (THC) stock dipped 1.22% while the broader market gained, although it had previously outperformed its sector and the S&P 500. Investors are anticipating its upcoming earnings report on July 24, 2026, with projected EPS and revenue increases. The company holds a Z

Tone
Neutral 50/100
Event
Earnings
Published
10 Jul 2026 22:10
Source
Market source
TradingView Direct company coverage

Tenet Healthcare Corporation Stock 12‑Month Price Target Raised to $244.9, Implies 17% Upside

Tenet Healthcare Corporation's average 12-month price target has been increased to $244.9, representing a nearly 17% potential upside from its July 7 closing price. This updated target is based on estimates from 20 analysts, with a consensus "Buy" rating across 24 covering analys

Tone
Positive 72/100
Event
Analyst action
Published
09 Jul 2026 11:12
Source
TradingView
TradingView Direct company coverage

Tenet Healthcare Corporation Stock 12‑Month Price Target Raised to $244.8, Implies 17% Upside

Tenet Healthcare Corporation's average 12-month stock price target has been increased to $244.8, up from $243.35, according to estimates from 20 analysts. This updated target suggests a potential upside of approximately 17% based on the July 7 closing price. The consensus rating

Tone
Positive 74/100
Event
Analyst action
Published
08 Jul 2026 07:42
Source
TradingView
DirectorsTalk Interviews Direct company coverage

Tenet Healthcare Corporation (THC) Stock Analysis: A Healthcare Giant with a Promising 19.37% Upside

Tenet Healthcare Corporation (THC) is highlighted as a compelling investment in the healthcare sector, with a market cap of $17.55 billion and a projected 19.37% upside based on target prices. The company demonstrates strong financials, including a robust EPS of $19.23, 30.29% RO

Tone
Positive 74/100
Event
Earnings
Published
06 Jul 2026 21:41
Source
DirectorsTalk Interviews
TradingView Direct company coverage

What's Making Tenet Healthcare Stock Stand Out Right Now?

Tenet Healthcare Corporation (THC) is well-positioned for growth, driven by expanding adjusted admissions and strong performance in its Ambulatory Care segment. The company has a Zacks Rank #2 (Buy) due to favorable demographic trends, solid organic growth, and consistent earning

Tone
Positive 74/100
Event
Market update
Published
06 Jul 2026 21:40
Source
TradingView
Market source Direct company coverage

Are Investors Undervaluing Tenet Healthcare (THC) Right Now?

The article analyzes why Tenet Healthcare (THC) appears to be undervalued based on Zacks' value investing metrics. THC currently holds a Zacks Rank #2 (Buy) and an "A" grade for Value, supported by a PEG ratio of 0.81, significantly lower than its industry average of 1.87, and a

Tone
Positive 73/100
Event
Market update
Published
06 Jul 2026 14:40
Source
Market source
Finviz Direct company coverage

THC - Tenet Healthcare Corp Latest SEC Filings

This article provides a detailed financial overview of Tenet Healthcare Corp (THC), including key financial metrics, stock performance data, and insider/institutional ownership percentages. It highlights the company's market capitalization, revenue, earnings per share, and variou

Tone
Neutral 50/100
Event
Earnings
Published
05 Jul 2026 21:09
Source
Finviz
Timothy Sykes Direct company coverage

Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings

Tenet Healthcare Corporation (NYSE: THC) shares jumped over 6.5% following positive analyst coverage ahead of its Q2 2026 earnings report on July 24. While Bank of America and TD Cowen trimmed their price targets, both maintained "Buy" ratings, citing sector-wide pressures but co

Tone
Positive 79/100
Event
Earnings
Published
04 Jul 2026 21:09
Source
Timothy Sykes
AlphaStreet Direct company coverage

Tenet Healthcare Jumps 5.7% Amid Sector-Wide Rally

Tenet Healthcare Corporation saw its stock surge 5.7% to $202.03, participating in a broader sector-wide rally that also benefited peers like HCA and UHS. This movement appears to be driven by shifting investor sentiment towards hospital operators, possibly due to improving funda

Tone
Positive 74/100
Event
Market update
Published
02 Jul 2026 21:09
Source
AlphaStreet
Investing.com Direct company coverage

Cantor Fitzgerald reiterates Tenet Healthcare stock rating on staffing trends

Cantor Fitzgerald maintained its Overweight rating and $245.00 price target for Tenet Healthcare (NYSE: THC), noting stable hiring in acute and ASC/Outpatient nursing but weaker physician data, with increased openings concentrated in Florida and Arizona. InvestingPro's Fair Value

Tone
Positive 72/100
Event
Analyst action
Published
02 Jul 2026 19:40
Source
Investing.com